Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
TISSUE DEVELOPMENT |
56 |
1518 |
2.371e-30 |
1.103e-26 |
2 |
EMBRYO DEVELOPMENT |
42 |
894 |
3.807e-26 |
8.856e-23 |
3 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
33 |
554 |
1.449e-23 |
2.248e-20 |
4 |
EPITHELIUM DEVELOPMENT |
40 |
945 |
3.749e-23 |
4.362e-20 |
5 |
TISSUE MORPHOGENESIS |
31 |
533 |
8.108e-22 |
7.545e-19 |
6 |
ORGAN MORPHOGENESIS |
36 |
841 |
6.546e-21 |
5.077e-18 |
7 |
EMBRYONIC MORPHOGENESIS |
30 |
539 |
1.435e-20 |
9.541e-18 |
8 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
47 |
1672 |
5.449e-20 |
3.169e-17 |
9 |
POSITIVE REGULATION OF GENE EXPRESSION |
47 |
1733 |
2.347e-19 |
1.213e-16 |
10 |
SKELETAL SYSTEM DEVELOPMENT |
27 |
455 |
3.049e-19 |
1.419e-16 |
11 |
PATTERN SPECIFICATION PROCESS |
26 |
418 |
4.756e-19 |
2.012e-16 |
12 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
47 |
1805 |
1.217e-18 |
4.718e-16 |
13 |
WNT SIGNALING PATHWAY |
24 |
351 |
1.443e-18 |
4.796e-16 |
14 |
REGIONALIZATION |
23 |
311 |
1.413e-18 |
4.796e-16 |
15 |
GLAND DEVELOPMENT |
25 |
395 |
1.632e-18 |
5.061e-16 |
16 |
CELL DEVELOPMENT |
42 |
1426 |
1.947e-18 |
5.663e-16 |
17 |
MORPHOGENESIS OF AN EPITHELIUM |
24 |
400 |
2.898e-17 |
7.491e-15 |
18 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
35 |
1021 |
2.868e-17 |
7.491e-15 |
19 |
TUBE DEVELOPMENT |
27 |
552 |
4.088e-17 |
1.001e-14 |
20 |
NEUROGENESIS |
40 |
1402 |
4.954e-17 |
1.152e-14 |
21 |
REGULATION OF CELL PROLIFERATION |
41 |
1496 |
7.269e-17 |
1.611e-14 |
22 |
REGULATION OF CELL DIFFERENTIATION |
40 |
1492 |
4.176e-16 |
8.832e-14 |
23 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
32 |
917 |
5.406e-16 |
1.094e-13 |
24 |
GROWTH |
23 |
410 |
6.171e-16 |
1.196e-13 |
25 |
RESPONSE TO ENDOGENOUS STIMULUS |
39 |
1450 |
9.886e-16 |
1.84e-13 |
26 |
RESPONSE TO LIPID |
31 |
888 |
1.685e-15 |
3.016e-13 |
27 |
EMBRYONIC ORGAN DEVELOPMENT |
22 |
406 |
5.798e-15 |
9.993e-13 |
28 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
29 |
801 |
6.43e-15 |
1.069e-12 |
29 |
TUBE MORPHOGENESIS |
20 |
323 |
9.081e-15 |
1.457e-12 |
30 |
POSITIVE REGULATION OF CELL PROLIFERATION |
29 |
814 |
9.726e-15 |
1.509e-12 |
31 |
MAMMARY GLAND DEVELOPMENT |
14 |
117 |
1.401e-14 |
2.103e-12 |
32 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
28 |
771 |
1.898e-14 |
2.76e-12 |
33 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
42 |
1848 |
1.962e-14 |
2.767e-12 |
34 |
CANONICAL WNT SIGNALING PATHWAY |
13 |
95 |
2.148e-14 |
2.855e-12 |
35 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
34 |
1192 |
2.089e-14 |
2.855e-12 |
36 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
14 |
122 |
2.54e-14 |
3.283e-12 |
37 |
UROGENITAL SYSTEM DEVELOPMENT |
19 |
299 |
2.812e-14 |
3.537e-12 |
38 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
36 |
1381 |
4.5e-14 |
5.51e-12 |
39 |
CELL FATE COMMITMENT |
17 |
227 |
4.849e-14 |
5.786e-12 |
40 |
NEGATIVE REGULATION OF CELL DEATH |
29 |
872 |
5.631e-14 |
6.55e-12 |
41 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
30 |
957 |
8.873e-14 |
1.007e-11 |
42 |
SKELETAL SYSTEM MORPHOGENESIS |
16 |
201 |
1.094e-13 |
1.213e-11 |
43 |
WOUND HEALING |
22 |
470 |
1.148e-13 |
1.242e-11 |
44 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
35 |
1360 |
1.634e-13 |
1.728e-11 |
45 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
32 |
1142 |
2.383e-13 |
2.464e-11 |
46 |
REGULATION OF CELL DEATH |
36 |
1472 |
3.05e-13 |
3.085e-11 |
47 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
35 |
1395 |
3.427e-13 |
3.392e-11 |
48 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
38 |
1656 |
3.943e-13 |
3.822e-11 |
49 |
NEURON DIFFERENTIATION |
28 |
874 |
4.129e-13 |
3.92e-11 |
50 |
RESPONSE TO WOUNDING |
23 |
563 |
5.104e-13 |
4.749e-11 |
51 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
10 |
53 |
8.325e-13 |
7.595e-11 |
52 |
RESPONSE TO ALCOHOL |
19 |
362 |
8.603e-13 |
7.698e-11 |
53 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
15 |
194 |
1.03e-12 |
9.041e-11 |
54 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
38 |
1710 |
1.062e-12 |
9.148e-11 |
55 |
DEVELOPMENTAL GROWTH |
18 |
333 |
2.205e-12 |
1.866e-10 |
56 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
26 |
799 |
2.315e-12 |
1.923e-10 |
57 |
OSSIFICATION |
16 |
251 |
3.362e-12 |
2.745e-10 |
58 |
RESPONSE TO HORMONE |
27 |
893 |
4.487e-12 |
3.6e-10 |
59 |
REGULATION OF CELL ADHESION |
23 |
629 |
4.957e-12 |
3.909e-10 |
60 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
28 |
983 |
6.915e-12 |
5.363e-10 |
61 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
39 |
1929 |
9.135e-12 |
6.968e-10 |
62 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
30 |
1152 |
9.96e-12 |
7.475e-10 |
63 |
RESPONSE TO GROWTH FACTOR |
20 |
475 |
1.157e-11 |
8.544e-10 |
64 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
28 |
1008 |
1.251e-11 |
9.097e-10 |
65 |
REGULATION OF MAPK CASCADE |
23 |
660 |
1.312e-11 |
9.39e-10 |
66 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
26 |
872 |
1.634e-11 |
1.152e-09 |
67 |
EMBRYONIC ORGAN MORPHOGENESIS |
16 |
279 |
1.665e-11 |
1.156e-09 |
68 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
37 |
1784 |
1.793e-11 |
1.227e-09 |
69 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
22 |
609 |
1.936e-11 |
1.305e-09 |
70 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
35 |
1618 |
2.344e-11 |
1.558e-09 |
71 |
EPITHELIAL CELL DIFFERENTIATION |
20 |
495 |
2.428e-11 |
1.591e-09 |
72 |
REGULATION OF ORGAN MORPHOGENESIS |
15 |
242 |
2.485e-11 |
1.606e-09 |
73 |
RESPONSE TO STEROID HORMONE |
20 |
497 |
2.61e-11 |
1.664e-09 |
74 |
REGULATION OF CELL DEVELOPMENT |
25 |
836 |
4.024e-11 |
2.53e-09 |
75 |
HEAD DEVELOPMENT |
23 |
709 |
5.495e-11 |
3.409e-09 |
76 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
27 |
1004 |
6.49e-11 |
3.974e-09 |
77 |
RESPONSE TO ESTROGEN |
14 |
218 |
7.449e-11 |
4.502e-09 |
78 |
FORMATION OF PRIMARY GERM LAYER |
11 |
110 |
7.711e-11 |
4.6e-09 |
79 |
REGULATION OF WNT SIGNALING PATHWAY |
16 |
310 |
8.022e-11 |
4.725e-09 |
80 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
36 |
1791 |
8.926e-11 |
5.192e-09 |
81 |
LOCOMOTION |
28 |
1114 |
1.281e-10 |
7.359e-09 |
82 |
MESODERM DEVELOPMENT |
11 |
118 |
1.661e-10 |
9.423e-09 |
83 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
24 |
823 |
1.754e-10 |
9.833e-09 |
84 |
GASTRULATION |
12 |
155 |
2.098e-10 |
1.162e-08 |
85 |
CONNECTIVE TISSUE DEVELOPMENT |
13 |
194 |
2.173e-10 |
1.189e-08 |
86 |
INTRACELLULAR SIGNAL TRANSDUCTION |
33 |
1572 |
2.253e-10 |
1.219e-08 |
87 |
CELL MOTILITY |
24 |
835 |
2.352e-10 |
1.243e-08 |
88 |
LOCALIZATION OF CELL |
24 |
835 |
2.352e-10 |
1.243e-08 |
89 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
10 |
93 |
2.807e-10 |
1.467e-08 |
90 |
KIDNEY EPITHELIUM DEVELOPMENT |
11 |
125 |
3.104e-10 |
1.605e-08 |
91 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
12 |
167 |
4.983e-10 |
2.548e-08 |
92 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
11 |
131 |
5.149e-10 |
2.604e-08 |
93 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
17 |
408 |
5.445e-10 |
2.724e-08 |
94 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
29 |
1275 |
5.828e-10 |
2.885e-08 |
95 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
20 |
602 |
7.629e-10 |
3.736e-08 |
96 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
27 |
1135 |
9.819e-10 |
4.759e-08 |
97 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
21 |
689 |
1.289e-09 |
6.182e-08 |
98 |
CARTILAGE DEVELOPMENT |
11 |
147 |
1.767e-09 |
8.392e-08 |
99 |
POSITIVE REGULATION OF CELL COMMUNICATION |
31 |
1532 |
2.229e-09 |
1.048e-07 |
100 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
22 |
788 |
2.515e-09 |
1.159e-07 |
101 |
CIRCULATORY SYSTEM DEVELOPMENT |
22 |
788 |
2.515e-09 |
1.159e-07 |
102 |
PROTEIN PHOSPHORYLATION |
24 |
944 |
2.713e-09 |
1.238e-07 |
103 |
CELLULAR RESPONSE TO LIPID |
17 |
457 |
3.027e-09 |
1.368e-07 |
104 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
25 |
1036 |
3.452e-09 |
1.53e-07 |
105 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
25 |
1036 |
3.452e-09 |
1.53e-07 |
106 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
17 |
465 |
3.925e-09 |
1.723e-07 |
107 |
DORSAL VENTRAL PATTERN FORMATION |
9 |
91 |
4.803e-09 |
2.089e-07 |
108 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
30 |
1492 |
5.012e-09 |
2.159e-07 |
109 |
PHOSPHORYLATION |
27 |
1228 |
5.358e-09 |
2.287e-07 |
110 |
OSTEOBLAST DIFFERENTIATION |
10 |
126 |
5.647e-09 |
2.389e-07 |
111 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
21 |
750 |
5.783e-09 |
2.424e-07 |
112 |
POSITIVE REGULATION OF LOCOMOTION |
16 |
420 |
6.549e-09 |
2.721e-07 |
113 |
MESODERM MORPHOGENESIS |
8 |
66 |
6.931e-09 |
2.854e-07 |
114 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
30 |
1517 |
7.351e-09 |
2.974e-07 |
115 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
15 |
365 |
7.327e-09 |
2.974e-07 |
116 |
CELL DEATH |
24 |
1001 |
8.5e-09 |
3.409e-07 |
117 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
10 |
134 |
1.026e-08 |
4.079e-07 |
118 |
POSITIVE REGULATION OF CELL ADHESION |
15 |
376 |
1.091e-08 |
4.3e-07 |
119 |
NON CANONICAL WNT SIGNALING PATHWAY |
10 |
140 |
1.564e-08 |
6.117e-07 |
120 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
10 |
144 |
2.05e-08 |
7.949e-07 |
121 |
RESPONSE TO ESTRADIOL |
10 |
146 |
2.34e-08 |
8.997e-07 |
122 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
12 |
236 |
2.498e-08 |
9.529e-07 |
123 |
CELLULAR COMPONENT MORPHOGENESIS |
22 |
900 |
2.775e-08 |
1.05e-06 |
124 |
NEURAL TUBE DEVELOPMENT |
10 |
149 |
2.842e-08 |
1.066e-06 |
125 |
CELL PROLIFERATION |
19 |
672 |
2.869e-08 |
1.068e-06 |
126 |
REGULATION OF STEM CELL DIFFERENTIATION |
9 |
113 |
3.267e-08 |
1.207e-06 |
127 |
REGULATION OF EMBRYONIC DEVELOPMENT |
9 |
114 |
3.529e-08 |
1.293e-06 |
128 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
11 |
197 |
3.776e-08 |
1.373e-06 |
129 |
NEPHRON DEVELOPMENT |
9 |
115 |
3.809e-08 |
1.374e-06 |
130 |
KIDNEY MORPHOGENESIS |
8 |
82 |
3.963e-08 |
1.418e-06 |
131 |
NEURON DEVELOPMENT |
19 |
687 |
4.068e-08 |
1.445e-06 |
132 |
REGULATION OF CELL MORPHOGENESIS |
17 |
552 |
4.875e-08 |
1.719e-06 |
133 |
SENSORY ORGAN DEVELOPMENT |
16 |
493 |
6.115e-08 |
2.139e-06 |
134 |
REPRODUCTION |
26 |
1297 |
7.023e-08 |
2.439e-06 |
135 |
NEGATIVE REGULATION OF GENE EXPRESSION |
28 |
1493 |
8.066e-08 |
2.78e-06 |
136 |
MESONEPHROS DEVELOPMENT |
8 |
90 |
8.273e-08 |
2.83e-06 |
137 |
IMMUNE SYSTEM DEVELOPMENT |
17 |
582 |
1.042e-07 |
3.488e-06 |
138 |
REGULATION OF SMOOTHENED SIGNALING PATHWAY |
7 |
62 |
1.041e-07 |
3.488e-06 |
139 |
TUBE FORMATION |
9 |
129 |
1.033e-07 |
3.488e-06 |
140 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
16 |
513 |
1.053e-07 |
3.5e-06 |
141 |
NEPHRON EPITHELIUM DEVELOPMENT |
8 |
93 |
1.07e-07 |
3.532e-06 |
142 |
REGULATION OF HYDROLASE ACTIVITY |
26 |
1327 |
1.104e-07 |
3.617e-06 |
143 |
CELL PROJECTION ORGANIZATION |
21 |
902 |
1.362e-07 |
4.431e-06 |
144 |
GLAND MORPHOGENESIS |
8 |
97 |
1.488e-07 |
4.809e-06 |
145 |
FOREBRAIN GENERATION OF NEURONS |
7 |
66 |
1.615e-07 |
5.148e-06 |
146 |
RESPONSE TO VITAMIN |
8 |
98 |
1.612e-07 |
5.148e-06 |
147 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
13 |
337 |
1.629e-07 |
5.156e-06 |
148 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
7 |
67 |
1.795e-07 |
5.642e-06 |
149 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
12 |
285 |
1.962e-07 |
6.127e-06 |
150 |
PEPTIDYL AMINO ACID MODIFICATION |
20 |
841 |
2.008e-07 |
6.228e-06 |
151 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
10 |
185 |
2.185e-07 |
6.733e-06 |
152 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
17 |
616 |
2.33e-07 |
7.132e-06 |
153 |
NEURON PROJECTION DEVELOPMENT |
16 |
545 |
2.387e-07 |
7.26e-06 |
154 |
ODONTOGENESIS |
8 |
105 |
2.756e-07 |
8.327e-06 |
155 |
MESENCHYME DEVELOPMENT |
10 |
190 |
2.799e-07 |
8.348e-06 |
156 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
10 |
190 |
2.799e-07 |
8.348e-06 |
157 |
RESPONSE TO NUTRIENT |
10 |
191 |
2.938e-07 |
8.708e-06 |
158 |
REGULATION OF TRANSFERASE ACTIVITY |
21 |
946 |
2.998e-07 |
8.829e-06 |
159 |
FOREBRAIN DEVELOPMENT |
13 |
357 |
3.151e-07 |
9.22e-06 |
160 |
EAR DEVELOPMENT |
10 |
195 |
3.559e-07 |
1.035e-05 |
161 |
REGULATION OF CYTOKINE PRODUCTION |
16 |
563 |
3.687e-07 |
1.066e-05 |
162 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
12 |
303 |
3.781e-07 |
1.086e-05 |
163 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
10 |
197 |
3.91e-07 |
1.116e-05 |
164 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY |
8 |
110 |
3.947e-07 |
1.12e-05 |
165 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
27 |
1518 |
4.172e-07 |
1.176e-05 |
166 |
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
4 |
11 |
4.348e-07 |
1.219e-05 |
167 |
EAR MORPHOGENESIS |
8 |
112 |
4.535e-07 |
1.263e-05 |
168 |
IN UTERO EMBRYONIC DEVELOPMENT |
12 |
311 |
4.989e-07 |
1.382e-05 |
169 |
RENAL TUBULE DEVELOPMENT |
7 |
78 |
5.156e-07 |
1.419e-05 |
170 |
BONE DEVELOPMENT |
9 |
156 |
5.23e-07 |
1.431e-05 |
171 |
CELLULAR RESPONSE TO ALCOHOL |
8 |
115 |
5.555e-07 |
1.512e-05 |
172 |
BONE MORPHOGENESIS |
7 |
79 |
5.628e-07 |
1.523e-05 |
173 |
METANEPHROS DEVELOPMENT |
7 |
81 |
6.683e-07 |
1.798e-05 |
174 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
9 |
162 |
7.186e-07 |
1.911e-05 |
175 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
9 |
162 |
7.186e-07 |
1.911e-05 |
176 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
6 |
53 |
8.674e-07 |
2.293e-05 |
177 |
POSITIVE REGULATION OF TRANSPORT |
20 |
936 |
1.08e-06 |
2.838e-05 |
178 |
HEART DEVELOPMENT |
14 |
466 |
1.089e-06 |
2.848e-05 |
179 |
NEGATIVE REGULATION OF CELL ADHESION |
10 |
223 |
1.214e-06 |
3.157e-05 |
180 |
RESPONSE TO NITROGEN COMPOUND |
19 |
859 |
1.246e-06 |
3.217e-05 |
181 |
REGULATION OF KINASE ACTIVITY |
18 |
776 |
1.251e-06 |
3.217e-05 |
182 |
REGULATION OF DNA METABOLIC PROCESS |
12 |
340 |
1.276e-06 |
3.262e-05 |
183 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
8 |
129 |
1.333e-06 |
3.377e-05 |
184 |
REGULATION OF CELL CYCLE |
20 |
949 |
1.336e-06 |
3.377e-05 |
185 |
REGULATION OF PROTEIN LOCALIZATION |
20 |
950 |
1.357e-06 |
3.414e-05 |
186 |
GLIOGENESIS |
9 |
175 |
1.37e-06 |
3.426e-05 |
187 |
RESPONSE TO EXTERNAL STIMULUS |
29 |
1821 |
1.389e-06 |
3.456e-05 |
188 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
10 |
228 |
1.484e-06 |
3.673e-05 |
189 |
RESPONSE TO INORGANIC SUBSTANCE |
14 |
479 |
1.506e-06 |
3.707e-05 |
190 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
15 |
552 |
1.535e-06 |
3.758e-05 |
191 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
10 |
229 |
1.544e-06 |
3.761e-05 |
192 |
INNER EAR MORPHOGENESIS |
7 |
92 |
1.592e-06 |
3.859e-05 |
193 |
REGULATION OF NEURON DIFFERENTIATION |
15 |
554 |
1.605e-06 |
3.869e-05 |
194 |
POSITIVE REGULATION OF KINASE ACTIVITY |
14 |
482 |
1.62e-06 |
3.885e-05 |
195 |
MUSCLE CELL DIFFERENTIATION |
10 |
237 |
2.103e-06 |
5.018e-05 |
196 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
17 |
724 |
2.16e-06 |
5.129e-05 |
197 |
CELL ACTIVATION |
15 |
568 |
2.182e-06 |
5.132e-05 |
198 |
REGULATION OF ERK1 AND ERK2 CASCADE |
10 |
238 |
2.184e-06 |
5.132e-05 |
199 |
PLACENTA DEVELOPMENT |
8 |
138 |
2.215e-06 |
5.18e-05 |
200 |
SENSORY ORGAN MORPHOGENESIS |
10 |
239 |
2.267e-06 |
5.275e-05 |
201 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
15 |
573 |
2.429e-06 |
5.623e-05 |
202 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
21 |
1079 |
2.491e-06 |
5.739e-05 |
203 |
IMMUNE SYSTEM PROCESS |
30 |
1984 |
2.545e-06 |
5.833e-05 |
204 |
MUSCLE STRUCTURE DEVELOPMENT |
13 |
432 |
2.654e-06 |
6.054e-05 |
205 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
19 |
905 |
2.683e-06 |
6.091e-05 |
206 |
STEM CELL DIFFERENTIATION |
9 |
190 |
2.703e-06 |
6.106e-05 |
207 |
REGULATION OF ORGANELLE ORGANIZATION |
22 |
1178 |
2.719e-06 |
6.112e-05 |
208 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
11 |
304 |
2.844e-06 |
6.362e-05 |
209 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
14 |
514 |
3.419e-06 |
7.612e-05 |
210 |
NEURON FATE COMMITMENT |
6 |
67 |
3.515e-06 |
7.789e-05 |
211 |
POSITIVE REGULATION OF PROTEIN IMPORT |
7 |
104 |
3.633e-06 |
7.975e-05 |
212 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
7 |
104 |
3.633e-06 |
7.975e-05 |
213 |
MALE SEX DIFFERENTIATION |
8 |
148 |
3.736e-06 |
8.162e-05 |
214 |
NERVE DEVELOPMENT |
6 |
68 |
3.836e-06 |
8.341e-05 |
215 |
NEPHRON TUBULE FORMATION |
4 |
18 |
3.899e-06 |
8.439e-05 |
216 |
ERBB2 SIGNALING PATHWAY |
5 |
39 |
3.948e-06 |
8.505e-05 |
217 |
REGULATION OF CELL CELL ADHESION |
12 |
380 |
4.026e-06 |
8.632e-05 |
218 |
REGULATION OF FAT CELL DIFFERENTIATION |
7 |
106 |
4.126e-06 |
8.807e-05 |
219 |
RESPONSE TO ABIOTIC STIMULUS |
20 |
1024 |
4.238e-06 |
9.005e-05 |
220 |
MAMMARY GLAND MORPHOGENESIS |
5 |
40 |
4.49e-06 |
9.495e-05 |
221 |
RESPONSE TO ACID CHEMICAL |
11 |
319 |
4.51e-06 |
9.495e-05 |
222 |
CELL FATE SPECIFICATION |
6 |
71 |
4.945e-06 |
0.0001036 |
223 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
8 |
154 |
5.018e-06 |
0.0001047 |
224 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
16 |
691 |
5.276e-06 |
0.0001096 |
225 |
NEGATIVE REGULATION OF LOCOMOTION |
10 |
263 |
5.31e-06 |
0.0001098 |
226 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
9 |
207 |
5.443e-06 |
0.0001121 |
227 |
SEX DIFFERENTIATION |
10 |
266 |
5.868e-06 |
0.0001203 |
228 |
BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS |
4 |
20 |
6.115e-06 |
0.0001248 |
229 |
REGULATION OF JNK CASCADE |
8 |
159 |
6.354e-06 |
0.0001291 |
230 |
CRANIAL NERVE DEVELOPMENT |
5 |
43 |
6.473e-06 |
0.0001309 |
231 |
POSITIVE REGULATION OF CELL CYCLE |
11 |
332 |
6.59e-06 |
0.0001327 |
232 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
13 |
472 |
6.935e-06 |
0.0001391 |
233 |
REGENERATION |
8 |
161 |
6.966e-06 |
0.0001391 |
234 |
NEURON PROJECTION MORPHOGENESIS |
12 |
402 |
7.13e-06 |
0.0001418 |
235 |
BODY MORPHOGENESIS |
5 |
44 |
7.267e-06 |
0.0001439 |
236 |
RESPONSE TO CYTOKINE |
16 |
714 |
7.961e-06 |
0.000157 |
237 |
CELL PART MORPHOGENESIS |
15 |
633 |
8.085e-06 |
0.0001581 |
238 |
REGULATION OF GROWTH |
15 |
633 |
8.085e-06 |
0.0001581 |
239 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
9 |
218 |
8.273e-06 |
0.0001611 |
240 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
8 |
166 |
8.72e-06 |
0.0001685 |
241 |
REGULATION OF CELL CYCLE PROCESS |
14 |
558 |
8.729e-06 |
0.0001685 |
242 |
BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY |
4 |
22 |
9.145e-06 |
0.0001758 |
243 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
7 |
121 |
9.908e-06 |
0.0001889 |
244 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
7 |
121 |
9.908e-06 |
0.0001889 |
245 |
CRANIAL NERVE MORPHOGENESIS |
4 |
23 |
1.102e-05 |
0.0002087 |
246 |
ENDOCRINE SYSTEM DEVELOPMENT |
7 |
123 |
1.103e-05 |
0.0002087 |
247 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
12 |
422 |
1.161e-05 |
0.0002183 |
248 |
INOSITOL LIPID MEDIATED SIGNALING |
7 |
124 |
1.163e-05 |
0.0002183 |
249 |
APOPTOTIC SIGNALING PATHWAY |
10 |
289 |
1.211e-05 |
0.0002263 |
250 |
EMBRYONIC PLACENTA DEVELOPMENT |
6 |
83 |
1.227e-05 |
0.0002284 |
251 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
16 |
740 |
1.242e-05 |
0.0002302 |
252 |
CELLULAR RESPONSE TO ACID CHEMICAL |
8 |
175 |
1.282e-05 |
0.0002358 |
253 |
HOMEOSTASIS OF NUMBER OF CELLS |
8 |
175 |
1.282e-05 |
0.0002358 |
254 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
5 |
50 |
1.377e-05 |
0.0002522 |
255 |
PALATE DEVELOPMENT |
6 |
85 |
1.408e-05 |
0.0002569 |
256 |
RESPONSE TO DRUG |
12 |
431 |
1.432e-05 |
0.0002603 |
257 |
REGULATION OF OSSIFICATION |
8 |
178 |
1.45e-05 |
0.0002626 |
258 |
POSITIVE REGULATION OF DNA REPLICATION |
6 |
86 |
1.506e-05 |
0.0002706 |
259 |
REGULATION OF REPRODUCTIVE PROCESS |
7 |
129 |
1.506e-05 |
0.0002706 |
260 |
FOREBRAIN REGIONALIZATION |
4 |
25 |
1.559e-05 |
0.0002769 |
261 |
REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
4 |
25 |
1.559e-05 |
0.0002769 |
262 |
PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
4 |
25 |
1.559e-05 |
0.0002769 |
263 |
CELL CYCLE |
22 |
1316 |
1.579e-05 |
0.0002793 |
264 |
TISSUE REGENERATION |
5 |
52 |
1.672e-05 |
0.0002947 |
265 |
BIOLOGICAL ADHESION |
19 |
1032 |
1.741e-05 |
0.0003057 |
266 |
REGULATION OF PROTEIN IMPORT |
8 |
183 |
1.772e-05 |
0.00031 |
267 |
RESPONSE TO EXTRACELLULAR STIMULUS |
12 |
441 |
1.797e-05 |
0.0003132 |
268 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
11 |
370 |
1.815e-05 |
0.0003152 |
269 |
REGULATION OF MESONEPHROS DEVELOPMENT |
4 |
26 |
1.834e-05 |
0.0003154 |
270 |
MESONEPHRIC TUBULE MORPHOGENESIS |
5 |
53 |
1.837e-05 |
0.0003154 |
271 |
SEGMENTATION |
6 |
89 |
1.834e-05 |
0.0003154 |
272 |
AXIS SPECIFICATION |
6 |
90 |
1.955e-05 |
0.0003344 |
273 |
EPITHELIAL CELL DEVELOPMENT |
8 |
186 |
1.993e-05 |
0.0003397 |
274 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
28 |
1977 |
2.038e-05 |
0.000345 |
275 |
REGULATION OF PROTEIN TARGETING |
10 |
307 |
2.039e-05 |
0.000345 |
276 |
GLIAL CELL DIFFERENTIATION |
7 |
136 |
2.123e-05 |
0.0003578 |
277 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
14 |
606 |
2.192e-05 |
0.0003683 |
278 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
5 |
55 |
2.205e-05 |
0.0003691 |
279 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
9 |
247 |
2.238e-05 |
0.0003732 |
280 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
10 |
312 |
2.341e-05 |
0.0003891 |
281 |
RESPONSE TO BMP |
6 |
94 |
2.506e-05 |
0.0004105 |
282 |
NEURAL TUBE FORMATION |
6 |
94 |
2.506e-05 |
0.0004105 |
283 |
CELLULAR RESPONSE TO BMP STIMULUS |
6 |
94 |
2.506e-05 |
0.0004105 |
284 |
MAMMARY GLAND DUCT MORPHOGENESIS |
4 |
28 |
2.488e-05 |
0.0004105 |
285 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
6 |
95 |
2.661e-05 |
0.0004345 |
286 |
CELL CYCLE PHASE TRANSITION |
9 |
255 |
2.875e-05 |
0.0004677 |
287 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
13 |
541 |
2.924e-05 |
0.0004724 |
288 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
13 |
541 |
2.924e-05 |
0.0004724 |
289 |
REGULATION OF CELL GROWTH |
11 |
391 |
3.015e-05 |
0.0004837 |
290 |
RESPIRATORY SYSTEM DEVELOPMENT |
8 |
197 |
3.01e-05 |
0.0004837 |
291 |
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
9 |
258 |
3.15e-05 |
0.000502 |
292 |
REGULATION OF PROTEOLYSIS |
15 |
711 |
3.149e-05 |
0.000502 |
293 |
REGULATION OF TRANSPORT |
26 |
1804 |
3.205e-05 |
0.0005089 |
294 |
REGULATION OF CELLULAR LOCALIZATION |
21 |
1277 |
3.229e-05 |
0.000511 |
295 |
LEUKOCYTE MIGRATION |
9 |
259 |
3.247e-05 |
0.0005122 |
296 |
POSITIVE REGULATION OF MAPK CASCADE |
12 |
470 |
3.354e-05 |
0.0005255 |
297 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
12 |
470 |
3.354e-05 |
0.0005255 |
298 |
CHONDROCYTE DIFFERENTIATION |
5 |
60 |
3.378e-05 |
0.0005275 |
299 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
19 |
1087 |
3.553e-05 |
0.0005522 |
300 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
6 |
100 |
3.56e-05 |
0.0005522 |
301 |
URETER DEVELOPMENT |
3 |
11 |
3.613e-05 |
0.0005548 |
302 |
BONE TRABECULA MORPHOGENESIS |
3 |
11 |
3.613e-05 |
0.0005548 |
303 |
PROSTATE GLANDULAR ACINUS DEVELOPMENT |
3 |
11 |
3.613e-05 |
0.0005548 |
304 |
PEPTIDYL SERINE MODIFICATION |
7 |
148 |
3.657e-05 |
0.000558 |
305 |
DIGESTIVE SYSTEM DEVELOPMENT |
7 |
148 |
3.657e-05 |
0.000558 |
306 |
NEURON PROJECTION GUIDANCE |
8 |
205 |
3.995e-05 |
0.0006075 |
307 |
RESPONSE TO METAL ION |
10 |
333 |
4.069e-05 |
0.0006147 |
308 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
11 |
404 |
4.058e-05 |
0.0006147 |
309 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
6 |
103 |
4.207e-05 |
0.0006294 |
310 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
6 |
103 |
4.207e-05 |
0.0006294 |
311 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
14 |
643 |
4.189e-05 |
0.0006294 |
312 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
7 |
152 |
4.336e-05 |
0.0006467 |
313 |
CARDIAC CHAMBER MORPHOGENESIS |
6 |
104 |
4.442e-05 |
0.0006603 |
314 |
RESPONSE TO MECHANICAL STIMULUS |
8 |
210 |
4.739e-05 |
0.0007022 |
315 |
MAMMARY GLAND EPITHELIAL CELL PROLIFERATION |
3 |
12 |
4.796e-05 |
0.0007084 |
316 |
SKIN DEVELOPMENT |
8 |
211 |
4.9e-05 |
0.0007216 |
317 |
RESPONSE TO RADIATION |
11 |
413 |
4.952e-05 |
0.0007269 |
318 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
23 |
1527 |
5.1e-05 |
0.0007462 |
319 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
8 |
213 |
5.238e-05 |
0.000764 |
320 |
SOMATIC STEM CELL POPULATION MAINTENANCE |
5 |
66 |
5.368e-05 |
0.0007806 |
321 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
4 |
34 |
5.476e-05 |
0.0007938 |
322 |
RESPONSE TO HYDROGEN PEROXIDE |
6 |
109 |
5.782e-05 |
0.0008329 |
323 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
8 |
216 |
5.78e-05 |
0.0008329 |
324 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
12 |
498 |
5.86e-05 |
0.0008416 |
325 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
8 |
218 |
6.166e-05 |
0.0008828 |
326 |
ORGAN GROWTH |
5 |
68 |
6.2e-05 |
0.000885 |
327 |
RESPONSE TO OXIDATIVE STRESS |
10 |
352 |
6.475e-05 |
0.0009213 |
328 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
8 |
220 |
6.574e-05 |
0.0009326 |
329 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
12 |
505 |
6.695e-05 |
0.0009469 |
330 |
HEAD MORPHOGENESIS |
4 |
36 |
6.89e-05 |
0.0009715 |
331 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
15 |
767 |
7.435e-05 |
0.001045 |
332 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
9 |
289 |
7.577e-05 |
0.001062 |
333 |
ENDODERM DEVELOPMENT |
5 |
71 |
7.632e-05 |
0.001066 |
334 |
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
4 |
37 |
7.689e-05 |
0.001071 |
335 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
10 |
360 |
7.802e-05 |
0.001084 |
336 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE |
3 |
14 |
7.863e-05 |
0.001086 |
337 |
CRANIOFACIAL SUTURE MORPHOGENESIS |
3 |
14 |
7.863e-05 |
0.001086 |
338 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
11 |
437 |
8.206e-05 |
0.001128 |
339 |
REGULATION OF RESPONSE TO STRESS |
22 |
1468 |
8.216e-05 |
0.001128 |
340 |
POSITIVE REGULATION OF DNA REPAIR |
4 |
38 |
8.553e-05 |
0.00117 |
341 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
10 |
368 |
9.354e-05 |
0.001276 |
342 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
16 |
876 |
9.402e-05 |
0.001279 |
343 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
7 |
172 |
9.466e-05 |
0.001284 |
344 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
8 |
232 |
9.522e-05 |
0.001288 |
345 |
MESENCHYMAL TO EPITHELIAL TRANSITION |
3 |
15 |
9.785e-05 |
0.001301 |
346 |
STRIATED MUSCLE CELL DIFFERENTIATION |
7 |
173 |
9.816e-05 |
0.001301 |
347 |
GABAERGIC NEURON DIFFERENTIATION |
3 |
15 |
9.785e-05 |
0.001301 |
348 |
NOSE DEVELOPMENT |
3 |
15 |
9.785e-05 |
0.001301 |
349 |
REGULATION OF CELL SUBSTRATE ADHESION |
7 |
173 |
9.816e-05 |
0.001301 |
350 |
RESPONSE TO TUMOR NECROSIS FACTOR |
8 |
233 |
9.81e-05 |
0.001301 |
351 |
REGULATION OF VASCULATURE DEVELOPMENT |
8 |
233 |
9.81e-05 |
0.001301 |
352 |
ENDODERMAL CELL DIFFERENTIATION |
4 |
40 |
0.0001049 |
0.001383 |
353 |
NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION |
4 |
40 |
0.0001049 |
0.001383 |
354 |
EXTRACELLULAR MATRIX DISASSEMBLY |
5 |
76 |
0.0001057 |
0.001389 |
355 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
6 |
122 |
0.0001082 |
0.001414 |
356 |
CELL CYCLE PROCESS |
18 |
1081 |
0.0001082 |
0.001414 |
357 |
REGULATION OF BMP SIGNALING PATHWAY |
5 |
77 |
0.0001125 |
0.001466 |
358 |
POSITIVE REGULATION OF GROWTH |
8 |
238 |
0.0001136 |
0.001477 |
359 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
4 |
41 |
0.0001157 |
0.001487 |
360 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
4 |
41 |
0.0001157 |
0.001487 |
361 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
4 |
41 |
0.0001157 |
0.001487 |
362 |
PROSTATE GLAND DEVELOPMENT |
4 |
41 |
0.0001157 |
0.001487 |
363 |
REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION |
3 |
16 |
0.0001199 |
0.001528 |
364 |
MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION |
3 |
16 |
0.0001199 |
0.001528 |
365 |
SOMITE DEVELOPMENT |
5 |
78 |
0.0001196 |
0.001528 |
366 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
10 |
381 |
0.0001243 |
0.001581 |
367 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
5 |
79 |
0.000127 |
0.001605 |
368 |
ERBB SIGNALING PATHWAY |
5 |
79 |
0.000127 |
0.001605 |
369 |
EPITHELIAL CELL MORPHOGENESIS |
4 |
42 |
0.0001273 |
0.001605 |
370 |
POSITIVE REGULATION OF CELL CELL ADHESION |
8 |
243 |
0.0001311 |
0.001649 |
371 |
TAXIS |
11 |
464 |
0.0001391 |
0.001744 |
372 |
NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION |
4 |
43 |
0.0001396 |
0.001747 |
373 |
MUSCLE CELL DEVELOPMENT |
6 |
128 |
0.0001408 |
0.001757 |
374 |
NEGATIVE REGULATION OF KIDNEY DEVELOPMENT |
3 |
17 |
0.0001449 |
0.001789 |
375 |
DORSAL VENTRAL NEURAL TUBE PATTERNING |
3 |
17 |
0.0001449 |
0.001789 |
376 |
MAMMARY GLAND ALVEOLUS DEVELOPMENT |
3 |
17 |
0.0001449 |
0.001789 |
377 |
MAMMARY GLAND LOBULE DEVELOPMENT |
3 |
17 |
0.0001449 |
0.001789 |
378 |
CELL JUNCTION ORGANIZATION |
7 |
185 |
0.0001489 |
0.001833 |
379 |
NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
5 |
82 |
0.0001516 |
0.001861 |
380 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
4 |
44 |
0.0001529 |
0.001872 |
381 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
12 |
552 |
0.0001546 |
0.001888 |
382 |
REGULATION OF PEPTIDASE ACTIVITY |
10 |
392 |
0.0001567 |
0.001909 |
383 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
6 |
132 |
0.0001667 |
0.00202 |
384 |
MAINTENANCE OF CELL NUMBER |
6 |
132 |
0.0001667 |
0.00202 |
385 |
MYELOID CELL DIFFERENTIATION |
7 |
189 |
0.0001699 |
0.002054 |
386 |
ORGAN MATURATION |
3 |
18 |
0.0001731 |
0.002066 |
387 |
REGULATION OF INTERLEUKIN 13 PRODUCTION |
3 |
18 |
0.0001731 |
0.002066 |
388 |
CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS |
3 |
18 |
0.0001731 |
0.002066 |
389 |
KIDNEY MESENCHYME DEVELOPMENT |
3 |
18 |
0.0001731 |
0.002066 |
390 |
SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION |
3 |
18 |
0.0001731 |
0.002066 |
391 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
15 |
829 |
0.0001751 |
0.002083 |
392 |
MESENCHYMAL CELL DIFFERENTIATION |
6 |
134 |
0.0001809 |
0.002147 |
393 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
7 |
191 |
0.0001813 |
0.002147 |
394 |
PROTEIN AUTOPHOSPHORYLATION |
7 |
192 |
0.0001872 |
0.002211 |
395 |
CELL GROWTH |
6 |
135 |
0.0001884 |
0.002219 |
396 |
DEVELOPMENTAL MATURATION |
7 |
193 |
0.0001933 |
0.002271 |
397 |
NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
6 |
136 |
0.0001961 |
0.002298 |
398 |
CYTOSKELETON ORGANIZATION |
15 |
838 |
0.0001968 |
0.0023 |
399 |
THYMUS DEVELOPMENT |
4 |
47 |
0.000198 |
0.002309 |
400 |
CELL CYCLE CHECKPOINT |
7 |
194 |
0.0001995 |
0.002321 |
401 |
CELLULAR RESPONSE TO RADIATION |
6 |
137 |
0.0002041 |
0.002368 |
402 |
REGULATION OF INTERLEUKIN 5 PRODUCTION |
3 |
19 |
0.0002047 |
0.002369 |
403 |
CELLULAR RESPONSE TO STRESS |
22 |
1565 |
0.0002066 |
0.002386 |
404 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
10 |
406 |
0.000208 |
0.002395 |
405 |
CELLULAR RESPONSE TO INTERLEUKIN 1 |
5 |
88 |
0.0002113 |
0.002422 |
406 |
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
5 |
88 |
0.0002113 |
0.002422 |
407 |
CELL CYCLE G2 M PHASE TRANSITION |
6 |
138 |
0.0002123 |
0.002427 |
408 |
DIGESTIVE TRACT MORPHOGENESIS |
4 |
48 |
0.000215 |
0.002452 |
409 |
CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
6 |
139 |
0.0002207 |
0.002511 |
410 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
8 |
263 |
0.000225 |
0.002554 |
411 |
AGING |
8 |
264 |
0.0002309 |
0.002614 |
412 |
POSITIVE REGULATION OF CHEMOKINE PRODUCTION |
4 |
49 |
0.000233 |
0.002632 |
413 |
PROTEIN LOCALIZATION |
24 |
1805 |
0.0002362 |
0.002661 |
414 |
TONGUE DEVELOPMENT |
3 |
20 |
0.0002397 |
0.002681 |
415 |
BONE GROWTH |
3 |
20 |
0.0002397 |
0.002681 |
416 |
DORSAL VENTRAL AXIS SPECIFICATION |
3 |
20 |
0.0002397 |
0.002681 |
417 |
ENDODERM FORMATION |
4 |
50 |
0.0002521 |
0.002806 |
418 |
RHO PROTEIN SIGNAL TRANSDUCTION |
4 |
50 |
0.0002521 |
0.002806 |
419 |
CARDIAC CHAMBER DEVELOPMENT |
6 |
144 |
0.0002672 |
0.00296 |
420 |
CELL CELL SIGNALING |
14 |
767 |
0.0002668 |
0.00296 |
421 |
REGULATION OF DNA BINDING |
5 |
93 |
0.0002736 |
0.003016 |
422 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
5 |
93 |
0.0002736 |
0.003016 |
423 |
RESPONSE TO IONIZING RADIATION |
6 |
145 |
0.0002774 |
0.003041 |
424 |
CHONDROCYTE DEVELOPMENT |
3 |
21 |
0.0002784 |
0.003041 |
425 |
NEGATIVE REGULATION OF MAPK CASCADE |
6 |
145 |
0.0002774 |
0.003041 |
426 |
COCHLEA MORPHOGENESIS |
3 |
21 |
0.0002784 |
0.003041 |
427 |
POSITIVE REGULATION OF CELL GROWTH |
6 |
148 |
0.0003096 |
0.003374 |
428 |
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
4 |
53 |
0.000316 |
0.003435 |
429 |
MYELOID LEUKOCYTE DIFFERENTIATION |
5 |
96 |
0.0003171 |
0.003439 |
430 |
POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT |
3 |
22 |
0.0003209 |
0.003473 |
431 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
9 |
352 |
0.0003312 |
0.003575 |
432 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
7 |
211 |
0.0003327 |
0.003583 |
433 |
CELLULAR COMPONENT DISASSEMBLY |
11 |
515 |
0.0003408 |
0.003662 |
434 |
HEART MORPHOGENESIS |
7 |
212 |
0.0003423 |
0.00367 |
435 |
NEGATIVE REGULATION OF CELL CYCLE |
10 |
433 |
0.000347 |
0.003712 |
436 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
6 |
152 |
0.0003572 |
0.003812 |
437 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
8 |
282 |
0.0003596 |
0.003828 |
438 |
PROSTATE GLAND MORPHOGENESIS |
3 |
23 |
0.0003674 |
0.003867 |
439 |
NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
3 |
23 |
0.0003674 |
0.003867 |
440 |
REGULATION OF KIDNEY DEVELOPMENT |
4 |
55 |
0.0003646 |
0.003867 |
441 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE III PROMOTER |
3 |
23 |
0.0003674 |
0.003867 |
442 |
TRABECULA FORMATION |
3 |
23 |
0.0003674 |
0.003867 |
443 |
REGULATION OF BINDING |
8 |
283 |
0.0003681 |
0.003867 |
444 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
6 |
153 |
0.0003699 |
0.003876 |
445 |
CELL CELL ADHESION |
12 |
608 |
0.0003732 |
0.003903 |
446 |
REGULATION OF HISTONE METHYLATION |
4 |
56 |
0.0003908 |
0.004077 |
447 |
PROTEIN LOCALIZATION TO NUCLEUS |
6 |
156 |
0.0004102 |
0.00427 |
448 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
9 |
363 |
0.0004142 |
0.004302 |
449 |
CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS |
3 |
24 |
0.000418 |
0.004313 |
450 |
RESPONSE TO STEROL |
3 |
24 |
0.000418 |
0.004313 |
451 |
POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY |
3 |
24 |
0.000418 |
0.004313 |
452 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
12 |
616 |
0.0004196 |
0.004319 |
453 |
REGULATION OF DEVELOPMENTAL GROWTH |
8 |
289 |
0.0004232 |
0.004347 |
454 |
LEUKOCYTE DIFFERENTIATION |
8 |
292 |
0.0004532 |
0.004644 |
455 |
CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS |
3 |
25 |
0.0004729 |
0.004804 |
456 |
RESPONSE TO PROSTAGLANDIN E |
3 |
25 |
0.0004729 |
0.004804 |
457 |
CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT |
3 |
25 |
0.0004729 |
0.004804 |
458 |
NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY |
3 |
25 |
0.0004729 |
0.004804 |
459 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
9 |
370 |
0.0004755 |
0.004821 |
460 |
REGULATION OF DNA REPLICATION |
6 |
161 |
0.000485 |
0.004906 |
461 |
SPINAL CORD DEVELOPMENT |
5 |
106 |
0.0005006 |
0.005042 |
462 |
CARDIAC VENTRICLE DEVELOPMENT |
5 |
106 |
0.0005006 |
0.005042 |
463 |
REGULATION OF GLUCOSE IMPORT |
4 |
60 |
0.0005091 |
0.005116 |
464 |
POSITIVE REGULATION OF HEMOPOIESIS |
6 |
163 |
0.0005178 |
0.005175 |
465 |
HOMEOSTATIC PROCESS |
19 |
1337 |
0.0005173 |
0.005175 |
466 |
RHYTHMIC PROCESS |
8 |
298 |
0.0005182 |
0.005175 |
467 |
RESPONSE TO RETINOIC ACID |
5 |
107 |
0.0005226 |
0.005207 |
468 |
NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT |
3 |
26 |
0.0005322 |
0.005258 |
469 |
MESODERMAL CELL DIFFERENTIATION |
3 |
26 |
0.0005322 |
0.005258 |
470 |
CELLULAR RESPONSE TO VITAMIN |
3 |
26 |
0.0005322 |
0.005258 |
471 |
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
3 |
26 |
0.0005322 |
0.005258 |
472 |
CELLULAR RESPONSE TO HYDROGEN PEROXIDE |
4 |
61 |
0.0005422 |
0.005334 |
473 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
4 |
61 |
0.0005422 |
0.005334 |
474 |
REGULATION OF CELL CYCLE ARREST |
5 |
108 |
0.0005453 |
0.005353 |
475 |
CELL DIVISION |
10 |
460 |
0.0005566 |
0.005452 |
476 |
PROTEIN COMPLEX BIOGENESIS |
17 |
1132 |
0.0005655 |
0.005516 |
477 |
PROTEIN COMPLEX ASSEMBLY |
17 |
1132 |
0.0005655 |
0.005516 |
478 |
SOMITOGENESIS |
4 |
62 |
0.0005769 |
0.005604 |
479 |
CARDIAC VENTRICLE MORPHOGENESIS |
4 |
62 |
0.0005769 |
0.005604 |
480 |
SKELETAL MUSCLE TISSUE REGENERATION |
3 |
27 |
0.000596 |
0.005742 |
481 |
REGULATION OF CARDIAC MUSCLE CELL CONTRACTION |
3 |
27 |
0.000596 |
0.005742 |
482 |
REGULATION OF HISTONE H3 K4 METHYLATION |
3 |
27 |
0.000596 |
0.005742 |
483 |
RESPONSE TO LITHIUM ION |
3 |
27 |
0.000596 |
0.005742 |
484 |
APPENDAGE DEVELOPMENT |
6 |
169 |
0.0006264 |
0.006009 |
485 |
LIMB DEVELOPMENT |
6 |
169 |
0.0006264 |
0.006009 |
486 |
REGULATION OF MITOTIC CELL CYCLE |
10 |
468 |
0.0006358 |
0.006087 |
487 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
5 |
112 |
0.0006436 |
0.006149 |
488 |
VASCULATURE DEVELOPMENT |
10 |
469 |
0.0006463 |
0.006162 |
489 |
REGULATION OF PROTEIN ACETYLATION |
4 |
64 |
0.0006509 |
0.006181 |
490 |
POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS |
4 |
64 |
0.0006509 |
0.006181 |
491 |
REGULATION OF CELL PROJECTION ORGANIZATION |
11 |
558 |
0.0006653 |
0.006263 |
492 |
HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS |
3 |
28 |
0.0006646 |
0.006263 |
493 |
NEGATIVE REGULATION OF NEURON DEATH |
6 |
171 |
0.0006662 |
0.006263 |
494 |
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
6 |
171 |
0.0006662 |
0.006263 |
495 |
METANEPHROS MORPHOGENESIS |
3 |
28 |
0.0006646 |
0.006263 |
496 |
PROTEIN HETEROOLIGOMERIZATION |
5 |
113 |
0.0006701 |
0.006287 |
497 |
CELLULAR RESPONSE TO RETINOIC ACID |
4 |
65 |
0.0006903 |
0.006437 |
498 |
REGULATION OF CHEMOKINE PRODUCTION |
4 |
65 |
0.0006903 |
0.006437 |
499 |
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
4 |
65 |
0.0006903 |
0.006437 |
500 |
RESPONSE TO INTERLEUKIN 1 |
5 |
115 |
0.0007256 |
0.006753 |
501 |
REGULATION OF HEMOPOIESIS |
8 |
314 |
0.0007295 |
0.006775 |
502 |
POSITIVE REGULATION OF LIPASE ACTIVITY |
4 |
66 |
0.0007314 |
0.006779 |
503 |
T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE |
3 |
29 |
0.000738 |
0.006813 |
504 |
EMBRYONIC HINDLIMB MORPHOGENESIS |
3 |
29 |
0.000738 |
0.006813 |
505 |
RESPONSE TO CORTICOSTEROID |
6 |
176 |
0.0007745 |
0.007136 |
506 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
5 |
117 |
0.0007845 |
0.007214 |
507 |
NEGATIVE REGULATION OF HYDROLASE ACTIVITY |
9 |
397 |
0.000786 |
0.007214 |
508 |
REGULATION OF MAP KINASE ACTIVITY |
8 |
319 |
0.0008082 |
0.007403 |
509 |
RESPONSE TO EPIDERMAL GROWTH FACTOR |
3 |
30 |
0.0008163 |
0.007447 |
510 |
CELLULAR RESPONSE TO ESTRADIOL STIMULUS |
3 |
30 |
0.0008163 |
0.007447 |
511 |
REGULATION OF CELL CYCLE PHASE TRANSITION |
8 |
321 |
0.0008415 |
0.007663 |
512 |
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT |
4 |
69 |
0.000865 |
0.007861 |
513 |
MITOTIC CELL CYCLE |
13 |
766 |
0.0008776 |
0.00796 |
514 |
REGULATION OF INTERLEUKIN 4 PRODUCTION |
3 |
31 |
0.0008997 |
0.008066 |
515 |
RESPONSE TO INTERLEUKIN 4 |
3 |
31 |
0.0008997 |
0.008066 |
516 |
NEURON FATE SPECIFICATION |
3 |
31 |
0.0008997 |
0.008066 |
517 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
3 |
31 |
0.0008997 |
0.008066 |
518 |
SCHWANN CELL DIFFERENTIATION |
3 |
31 |
0.0008997 |
0.008066 |
519 |
MATERNAL PLACENTA DEVELOPMENT |
3 |
31 |
0.0008997 |
0.008066 |
520 |
RESPONSE TO KETONE |
6 |
182 |
0.0009219 |
0.00825 |
521 |
EYE DEVELOPMENT |
8 |
326 |
0.0009297 |
0.008303 |
522 |
REGULATION OF NEURON DEATH |
7 |
252 |
0.0009535 |
0.008499 |
523 |
SKIN EPIDERMIS DEVELOPMENT |
4 |
71 |
0.000963 |
0.008568 |
524 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
6 |
184 |
0.0009756 |
0.008663 |
525 |
ENDOCARDIAL CUSHION DEVELOPMENT |
3 |
32 |
0.0009883 |
0.008677 |
526 |
POSITIVE REGULATION OF MITOTIC CELL CYCLE |
5 |
123 |
0.0009825 |
0.008677 |
527 |
POSITIVE REGULATION OF BMP SIGNALING PATHWAY |
3 |
32 |
0.0009883 |
0.008677 |
528 |
PROXIMAL DISTAL PATTERN FORMATION |
3 |
32 |
0.0009883 |
0.008677 |
529 |
REGULATION OF ACTIN FILAMENT BASED MOVEMENT |
3 |
32 |
0.0009883 |
0.008677 |
530 |
T CELL DIFFERENTIATION |
5 |
123 |
0.0009825 |
0.008677 |
531 |
PEPTIDYL TYROSINE MODIFICATION |
6 |
186 |
0.001032 |
0.00904 |
532 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
12 |
684 |
0.001049 |
0.009175 |
533 |
LEUKOCYTE ACTIVATION |
9 |
414 |
0.001055 |
0.009203 |
534 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
5 |
125 |
0.001056 |
0.009203 |
535 |
ERYTHROCYTE HOMEOSTASIS |
4 |
73 |
0.001069 |
0.009277 |
536 |
CELLULAR RESPONSE TO KETONE |
4 |
73 |
0.001069 |
0.009277 |
537 |
REGULATION OF CYTOSKELETON ORGANIZATION |
10 |
502 |
0.001084 |
0.009391 |
538 |
RESPONSE TO UV |
5 |
126 |
0.001094 |
0.009466 |
539 |
SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
5 |
127 |
0.001134 |
0.009788 |